UBS AG Logo
Login | Preferences | Contact |engita
UBS Fund Gate - Luxembourg
   
Home
News
Products
Compare products
Virtual portfolios
E-mail subscription
General information
 
 
Search for products
Overview
Search by criteria
Product information
UBS products  ›  Product information
UBS (Lux) Equity Fund - Greater China (USD) (CHF hedged) P-acc
ISIN no.:  LU0763739066
PDF
HTM
PDF
Overview  
Category profile
UBS Emerging Market Funds Investors are benefiting from above-average return opportunities over time, reducing risk exposure through diversification and investing with experienced professionals.

Fund description
Actively managed equity fund investing within the Greater China region which includes China, Hong Kong and Taiwan.
Diversified across sectors offering broad coverage of Greater China markets.
Diversified across sectors
Exploits a disciplined investment philosophy and globally integrated state-of-the-art fundamental research
The exchange rate risk between USD and CHF is largely hedged.

Key benefits
Easy access to the Chinese, Hong Kong and Taiwanese markets
Investors gain access to “A” class shares as UBS is recognised as a qualified financial investor in China
Investors benefit from UBS being one of the few asset managers with a truly global investment platform
UBS’s proprietary fundamental valuation approach allows consistent identification of the potential most attractive companies

Risks
UBS Emerging Market Funds invest in equities and may therefore be subject to high fluctuations in value. For this reason, an investment horizon of at least five years and corresponding risk tolerance and capacity are required. As these UBS Funds pursue an active management style, each Fund's performance can deviate from that of its reference index. Investors should also be aware of the political and social challenges that emerging markets face. All investments are subject to market fluctuations. Every Fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk).

Product features
Product category
UBS Emerging Market Funds
Equities
Product domicile
Luxembourg
Portfolio management
UBS Asset Management, Hongkong
Fund management
UBS Fund Management (Luxembourg) S.A.
Custodian bank
UBS Europe SE, Luxembourg Branch
Day of inception
April 2, 2012
Currency of account
USD
Currency of unit class
CHF
Close of financial year
November 30
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Management fee
1.87% p.a.
Total expense ratio (TER)
2.40% p.a.
Swing pricing
yes
Minimum investment
n.a.

Current data
Net asset value
CHF207.47
15/12/2017
High - last 12 months
CHF216.36
21/11/2017
Low - last 12 months
CHF138.09
23/12/2016
Assets of the unit class in mn
CHF14.38
15/12/2017
Total product assets in mn
CHF793.17
15/12/2017

Statistical data
 
2 years
5 years
 
Sharpe Ratio
1.54
0.90
30/11/2017
Risk Free Rate
-0.89%
-0.53%
30/11/2017

Symbols
ISIN no.
LU0763739066
Bloomberg Ticker
UBSGCCH LX
Telekurs Id
n.a.

 
Performance chart (CHF-based, as of December 15, 2017)
Indexed, Month-end values
Performance chart (CHF-based, as of December 15, 2017)

Past performance is not a reliable indicator of future results.

Performance (in %, as of December 15, 2017)
in %
1
year
3
years
5
years
ø p.a.
5 years
CHF
45.64
62.54
95.69
14.37
EUR
34.03
67.29
102.63
15.17
The performance shown does not take account of any commissions, entry or exit charges.
These figures refer to the past. Past performance is not a reliable indicator of future results.

By sector (in %, as of November 30, 2017)
Chart

By the 10 largest equity positions (in %, as of November 30, 2017)
TENCENT HOLDINGS LTD
9.46
ALIBABA GROUP HOLDING LTD
9.41
PING AN INSURANCE H CNY1
9.13
TAL EDUCATION GROUP ADR
8.23
NETEASE INC-ADR
4.58
TAIWAN SEMICONDUCTOR TWD10
4.09
SHENZHEN INTL HOLDINGS
3.79
ANHUI GUJING DISTL B CNY1
3.20
BAIDU.COM ADS
3.13
CSPC PHARMACEUTICAL GROUP LT
2.38

By investment domicile (in %, as of November 30, 2017)
Chart
Additional fees (e.g. entry or exit fees) may be charged by the Distributor. Please refer to your financial adviser for more details. For a definition of financial terms refer to the glossary available at www.ubs.com/glossary.
For marketing and information purposes by UBS. UBS funds under Luxembourg law. Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS Fund Services (Luxembourg) S.A., P.O. Box 91, L-2010 Luxembourg or from UBS Europe SE, Luxembourg Branch, P.O. Box 2, L-2010 Luxembourg. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management
Source for all data and charts (if not indicated otherwise): UBS Asset Management
No responsibility is taken for the correctness of the information provided above.

Important legal information - please read the disclaimer before proceeding.
Products and services in these web pages may not be available for residents of certain nations.
Please consult the sales restrictions relating to the service in question for further information.
© UBS 1998-2017. All rights reserved.
Privacy Policy